Document Detail


Tc-99m SPECT Sestamibi for the Measurement of Infarct Size.
MedLine Citation:
PMID:  21821535     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
There are a variety of approaches to assess the efficacy of reperfusion therapy, and myocardial protection, in acute myocardial infarction. This review summarizes the available evidence validating the use of technetium-99m sestamibi single-photon emission computed tomography (SPECT) for this purpose. Multiple lines of evidence have validated its clinical utility. SPECT sestamibi infarct size has been used as an endpoint in multiple randomized clinical trials. A smaller number of clinical trials have used both early and later imaging with SPECT sestamibi to assess myocardium at risk and myocardial salvage. SPECT sestamibi has a number of limitations which must be recognized. Nevertheless, SPECT sestamibi infarct size is a well-validated measurement with a long track record of performance as an endpoint in multicenter, randomized clinical trials.
Authors:
Raymond J Gibbons
Related Documents :
23771945 - Efficacy of epicardially-delivered adipose stroma cell sheets in dilated cardiomyopathy.
23178125 - Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocar...
3888065 - Intracardiac thrombi and systemic thromboembolism: detection, incidence, and treatment.
19294335 - Interatrial thrombus-in-transit resulting in paradoxical thromboembolism.
20920875 - Automatic microvolt t-wave alternans identification in relation to ecg interferences su...
15295725 - Efficacy of lower-energy biphasic shocks for transthoracic defibrillation: a follow-up ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology and therapeutics     Volume:  16     ISSN:  1940-4034     ISO Abbreviation:  J. Cardiovasc. Pharmacol. Ther.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602617     Medline TA:  J Cardiovasc Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  321-31     Citation Subset:  IM    
Affiliation:
1Mayo Clinic, Rochester, MN, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage.
Next Document:  Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): ...